[Answered] The designer drug Rohypnol is commonly known as __________

This topic contains a solution. Click here to go to the answer

Author Question: The designer drug Rohypnol is commonly known as ___________. a. ecstasy b. vitamin K c. ice d. ... (Read 32 times)

burchfield96

Hero Member
Posts: 610

on: Jun 22, 2018

The designer drug Rohypnol is commonly known as ___________.

a. ecstasy
b. vitamin K
c. ice
d. roofies

Question 2

Ecstasy is also known as ______________.

a. MDMA
b. LSD
c. GHB
d. Special K

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

jordangronback

Sr. Member
Posts: 339

Reply #1 on: Jun 22, 2018

Answer to Question 1

d

Answer to Question 2

a

burchfield96

Member
Posts: 610

Reply 2 on: Jun 22, 2018

TYSM

bimper21

Member
Posts: 309

Reply 3 on: Yesterday

YES! Correct, THANKS for helping me on my review

« previous next »

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.